MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

Liu, Lina; Zhang, Yan; Hu, Xi; Zhou, Hui; Jiang, Chenyang; Guo, Yinlong; Cang, Shundong

doi:10.1016/j.tranon.2023.101723

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Book1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

microRNAs in Bone Disorders

Palmini,

Brandi

2024

Endocrinology

View full text Add to dashboard Cite

microRNAs in Bone Disorders

Palmini,

Brandi

2024

Endocrinology

View full text Add to dashboard Cite

MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel

Rasoolnezhad,

Safaralizadeh,

Hosseinpour Feizi

et al. 2023

Mol Biol Rep

View full text Add to dashboard Cite

BackgroundChemotherapy is a predominant strategy for breast cancer (BC) treatment and paclitaxel (PTX) has been known as a conventional chemotherapeutic drug. However, insensitivity of BC cells to PTX limits the antitumor effects of this agent. MicroRNAs are closely related to BC which are suggested as therapeutic factors in the combination therapy of BC. We examined the possible e cacy of miR-138-5p restoration in combination with PTX to impove BC treatment. Methods and ResultsThe human breast cancer cell line MDA-MB-231 was transfected with miR-138-5p mimics and treated with PTX, in a combined or separate manner. The MTT assay was accomplished to determine inhibitory doses of PTX. Annexin V/PI assay and DAPI staining were applied to evaluate apoptosis. Flow cytometry was applied to determine cells arrested in different phases of the cell-cycle. Expression levels of molecular factors involved in cell migration, proliferation, apoptosis, and cell cycle were determined via western blotting and qRT-PCR.MiR-138-5p combined with PTX suppressed cell migration via modulating MMP2, E-cadherin, and vimentin and sustained colony formation and proliferation by downregulation of the PI3K/AKT pathway.qRT-PCR showed that miR-138-5p increases BC chemosensitivity to PTX by regulating the apoptosis factors, including Bcl-2, Bax, Caspase 3, and Caspase 9. Moreover, miR-138-5p restoration and paclitaxel therapy combined arrest the cells in the sub-G 1 and G 1 phases of cell cycle by regulating p21, CCND1, and CDK4. ConclusionsRestored miR-138-5p intensi ed the chemosensitivity of MDA-MB-231 cell line to PTX, and the combination of miR-138-5p with PTX might represent a novel approach in BC treatment.

show abstract